| Key Financial Ratios of Jagsonpal Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
3.00 |
2.75 |
-4.41 |
4.53 |
1.24 |
|
| Diluted EPS (Rs.) |
3.00 |
2.75 |
-4.41 |
4.53 |
1.24 |
|
| Cash EPS (Rs.) |
3.44 |
3.14 |
-4.29 |
5.29 |
2.42 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
39.39 |
36.89 |
34.43 |
38.96 |
34.55 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
42.38 |
39.88 |
37.43 |
41.96 |
37.55 |
|
| Dividend / Share(Rs.) |
0.50 |
0.25 |
0.10 |
0.10 |
0.10 |
|
| Revenue from Operations/Share (Rs.) |
60.53 |
64.22 |
48.47 |
54.92 |
54.77 |
|
| PBDIT/Share (Rs.) |
4.22 |
4.11 |
-4.07 |
2.38 |
4.76 |
|
| PBIT/Share (Rs.) |
3.79 |
3.72 |
-4.19 |
1.62 |
3.58 |
|
| PBT/Share (Rs.) |
3.59 |
3.44 |
-4.44 |
5.50 |
1.56 |
|
| Net Profit/Share (Rs.) |
3.00 |
2.75 |
-4.41 |
4.53 |
1.24 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
6.97 |
6.39 |
-8.38 |
4.33 |
8.68 |
|
| PBIT Margin (%) |
6.26 |
5.79 |
-8.63 |
2.94 |
6.53 |
|
| PBT Margin (%) |
5.93 |
5.35 |
-9.15 |
10.00 |
2.84 |
|
| Net Profit Margin (%) |
4.96 |
4.28 |
-9.09 |
8.24 |
2.26 |
|
| Return on Networth / Equity (%) |
7.62 |
7.46 |
-12.80 |
11.62 |
3.59 |
|
| Return on Capital Employed (%) |
8.69 |
9.06 |
-10.83 |
3.74 |
3.19 |
|
| Return on Assets (%) |
5.35 |
5.31 |
-8.89 |
8.31 |
2.04 |
|
| Total Debt/Equity (X) |
0.05 |
0.04 |
0.09 |
0.08 |
0.43 |
|
| Asset Turnover Ratio (%) |
107.90 |
123.91 |
97.82 |
100.88 |
90.08 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
2.89 |
3.46 |
3.31 |
3.74 |
1.76 |
|
| Quick Ratio (X) |
2.00 |
2.30 |
1.51 |
2.12 |
1.07 |
|
| Inventory Turnover Ratio (X) |
5.41 |
5.15 |
2.47 |
3.02 |
3.60 |
|
| Dividend Payout Ratio (NP) (%) |
16.64 |
10.94 |
-2.72 |
2.20 |
8.05 |
|
| Dividend Payout Ratio (CP) (%) |
14.55 |
9.59 |
-2.80 |
1.89 |
4.12 |
|
| Earnings Retention Ratio (%) |
83.36 |
89.06 |
102.72 |
97.80 |
91.95 |
|
| Cash Earnings Retention Ratio (%) |
85.45 |
90.41 |
102.80 |
98.11 |
95.88 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
12.31 |
34.15 |
64.26 |
87.68 |
108.76 |
|
| EV/Net Operating Revenue (X) |
0.08 |
0.20 |
0.51 |
0.61 |
0.76 |
|
| EV/EBITDA (X) |
1.11 |
3.17 |
-6.03 |
14.06 |
8.72 |
|
| MarketCap/Net Operating Revenue (X) |
0.29 |
0.41 |
0.55 |
0.69 |
0.60 |
|
| Retention Ratios (%) |
83.35 |
89.05 |
102.72 |
97.79 |
91.94 |
|
| Price/BV (X) |
0.44 |
0.71 |
0.78 |
0.98 |
0.95 |
|
| Price/Net Operating Revenue |
0.29 |
0.41 |
0.55 |
0.69 |
0.60 |
|
| Earnings Yield |
0.17 |
0.10 |
-0.16 |
0.12 |
0.04 |
|
Source : Dion Global Solutions Limited
